Strategic focus of TAs are key success factors of pharmaceutical industry for both research based pharmaceutical companies and generic companies.

For generic company, plan of its portfolio and pipeline in

China, create synergy and improvement of efficiency of sales

force, establish brand equity for high quality generics.

For research based pharmaceutical companies, strategic

planning in China of its competitive advantages, efficiency of

operation, field force optimization, maximize the capture of

market opportunity and return of investment.